GlaxoSmithKline (GSK) to Fully Buy Cellzome AG for $99 Million
5/15/2012 7:48:56 AM
More...
|
Cellzome AG Awarded UK's Technology Strategy Board Grant as Part of the Regenerative Medicine Program
12/6/2011 9:06:40 AM
More...
|
Cellzome AG Founder Wins EU Women Innovators Award
12/6/2011 9:04:15 AM
More...
|
Cellzome AG Proteomic Study Published in the Journal Nature Paves the Way for New Treatment for Incurable Leukaemia Using an Epigenetic Inhibitor
10/3/2011 11:59:22 AM
More...
|
Cellzome AG Achieves Clinical Candidate Milestone from Inflammation Alliance with GlaxoSmithKline (GSK)
9/14/2011 10:30:34 AM
More...
|
Cellzome AG to Study Epigenetic Factors with Neusentis
5/10/2011 11:06:06 AM
More...
|
Cellzome AG Builds Scientific Advisory Board with World-Leading Experts in Proteomics, Epigenetics and Immunology
2/23/2011 9:53:33 AM
More...
|
Cellzome AG Announces Achievement of Second Milestone in Epigenetics Collaboration with GlaxoSmithKline (GSK)
2/8/2011 9:48:32 AM
More...
|
Asterand plc (ATD.L)’s Subsidiary BioSeek Signs Agreement with Cellzome AG
9/23/2010 11:12:48 AM
More...
|
Cellzome AG Technology Used to Unravel Novel Regulatory Mechanism in Cancer Signaling Pathway
9/17/2009 10:07:41 AM
More...
|
|